Synthetic Biologics Inc (SYN.A)

SYN.A on American Stock Exchange

1.08USD
8 Feb 2016
Change (% chg)

$-0.07 (-6.09%)
Prev Close
$1.15
Open
$1.14
Day's High
$1.16
Day's Low
$1.04
Volume
54,773
Avg. Vol
86,633
52-wk High
$4.32
52-wk Low
$1.04

SYN.A

Chart for SYN.A

About

Synthetic Biologics, Inc. is a clinical-stage biotechnology company. The Company is developing pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV)... (more)

Overall

Beta: 1.35
Market Cap(Mil.): $98.07
Shares Outstanding(Mil.): 90.81
Dividend: --
Yield (%): --

Financials

  SYN.A Industry Sector
P/E (TTM): -- 36.97 38.72
EPS (TTM): -0.53 -- --
ROI: -268.03 6.90 14.47
ROE: -264.88 8.97 15.40
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks